Sibylle Hauser

Senior Vice President, Corporate Development & Strategy at Open Biopharma Research and Training Institute

Sibylle Hauser is a seasoned professional in the life sciences industry, currently serving as Senior Vice President of Corporate Development & Strategy at Open Biopharma Research and Training Institute and as SVP of Life Sciences at Global Bridge LLC. With extensive experience in fundraising strategies and corporate development, Sibylle has held notable positions such as Executive Director of Innovation & Entrepreneurship at California Life Sciences and a member of the Scientific Investment Advisory Committee at the Gates Center for Regenerative Medicine. As a board member of SiVEC Biotechnologies, Sibylle supports the development of innovative biotherapeutic delivery platforms. Previous roles include Strategic Advisor at Richtr Financial Studio and Principal Strategist at Hauser Consulting, emphasizing business development services for therapeutics and diagnostics. Sibylle holds an MBA in International Marketing from FAU Erlangen-Nürnberg and a Matura in Biochemistry from Albert-Schweitzer-Gymnasium Erlangen.

Location

San Diego, United States

Links

Previous companies


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices


Open Biopharma Research and Training Institute

Open Biopharma Research and Training Institute is a 501(c)(3) nonprofit whose mission is to reduce the price of biopharmaceuticals, and thus reduce drug prices. To do this our goal is to drive innovation that reduces the cost of biopharma manufacturing and as an educational institution, to ensure the training of life sciences professionals for the newest biopharmaceutical manufacturing and related technologies. Open Biopharma is located in the heart of the Southern California Biocluster, in Carlsbad California. The 45,000 sqft virtual cGMP facility is the first FutureFacility™ built in collaboration with CRB and designed around the ballroom concept. We provide training and demonstration on cutting edge equipment and technologies, such as single use and continuous processing, alongside industry standards like the basics of aseptic processing. Open Biopharma aims to test the newest technologies and pioneer platforms that represent the future of biomanufacturing. We aim to generate real-life manufacturing data in a virtual cGMP environment that can accelerate the acceptance of new technologies by the industry and by regulatory authorities. We provide a unique “sandbox” that allows our partners to “test-drive” the newest biomanufacturing methodologies and equipment. Our unique open platform allows for different equipment from multiple vendors to be tested together in our “Sandbox” ballrooms. The Open, in Open Biopharma, also means that we evaluate, demo and train on any equipment that has an impact on reducing the cost of biomanufacturing or addresses the manufacturing needs of novel therapeutics. Open Biopharma partners with leading industry organizations, like the PDA, ISPE, and other life science industry members. We focus on providing hands-on training in a real life cGMP production environment. Whether its training, research, or partnership, please reach out to us and discover the opportunities that working with the future can bring. Learn@openbiopharma.org


Employees

1-10

Links